IRIS
GAMBA, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.697
AS - Asia 2.186
EU - Europa 1.936
SA - Sud America 248
AF - Africa 39
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.114
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.642
CN - Cina 1.352
IE - Irlanda 444
SG - Singapore 435
UA - Ucraina 317
FI - Finlandia 258
RU - Federazione Russa 208
DE - Germania 202
HK - Hong Kong 201
BR - Brasile 198
IT - Italia 131
GB - Regno Unito 123
SE - Svezia 121
VN - Vietnam 58
CA - Canada 32
PL - Polonia 32
FR - Francia 30
IN - India 27
BD - Bangladesh 26
AR - Argentina 24
MX - Messico 18
BE - Belgio 17
ZA - Sudafrica 16
IR - Iran 15
JP - Giappone 12
NL - Olanda 11
EC - Ecuador 10
ES - Italia 9
IQ - Iraq 9
MU - Mauritius 9
ID - Indonesia 8
AU - Australia 5
CZ - Repubblica Ceca 5
PK - Pakistan 5
AT - Austria 4
BH - Bahrain 4
CH - Svizzera 4
LT - Lituania 4
PY - Paraguay 4
TR - Turchia 4
VE - Venezuela 4
CL - Cile 3
EG - Egitto 3
GR - Grecia 3
MA - Marocco 3
OM - Oman 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
LV - Lettonia 1
MG - Madagascar 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SN - Senegal 1
UY - Uruguay 1
Totale 7.114
Salva come PNG Salva come JPEG
Città #
Dublin 441
Chandler 431
Jacksonville 405
Nanjing 322
Beijing 219
Singapore 205
Ashburn 201
Hong Kong 201
Dallas 166
Boardman 146
Nanchang 117
Shenyang 92
Lawrence 89
Princeton 89
Changsha 88
Hebei 86
Wilmington 85
Jiaxing 75
Helsinki 71
Los Angeles 69
Medford 61
Ann Arbor 59
Tianjin 58
Hangzhou 47
Moscow 39
Woodbridge 34
Buffalo 33
Munich 28
New York 24
Milan 23
Shanghai 22
Des Moines 20
Ho Chi Minh City 20
São Paulo 19
Warsaw 18
Brussels 17
Redondo Beach 17
Verona 17
Seattle 16
Turku 16
Kunming 15
Houston 14
Jinan 14
Radomsko 14
San Francisco 14
Toronto 13
Brooklyn 12
Chicago 12
Council Bluffs 12
Hanoi 12
Tokyo 12
Norwalk 11
Poplar 11
Taizhou 11
Denver 10
Johannesburg 10
Ningbo 10
Fairfield 9
Guangzhou 9
Leawood 9
Manchester 9
Mexico City 9
Zhengzhou 9
Boston 8
Chennai 8
London 8
Orem 8
Santa Clara 8
Stockholm 8
Dearborn 7
Montreal 7
Mumbai 7
Rio de Janeiro 7
Atlanta 6
Auburn Hills 6
Fuzhou 6
Phoenix 6
The Dalles 6
Dhaka 5
Falkenstein 5
Falls Church 5
Rome 5
Zanjan 5
Amsterdam 4
Biên Hòa 4
Bologna 4
City of London 4
Cotia 4
Curitiba 4
Lanzhou 4
Nuremberg 4
Pavia 4
Pune 4
Quito 4
Vienna 4
Washington 4
Zapopan 4
Ardabil 3
Bern 3
Buenos Aires 3
Totale 4.643
Salva come PNG Salva come JPEG
Nome #
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 133
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 128
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 128
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 123
An unconventional case of scurvy. 113
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 111
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 110
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 109
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 108
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 108
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 104
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 103
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 102
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 102
Acquired von Willebrand syndrome in inflammatory bowel disease 101
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 99
Clotting alterations in primary systemic amyloidosis. 98
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 96
La valutazione della qualità della vita e della artropatia nel paziente emofilico adulto. 95
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 94
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. 94
Renal diseases in haemophilic patients: pathogenesis and clinical management. 93
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 92
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 92
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. 91
Platelet-independent defect in hemostasis associated with sirolimus use 90
Valutazione dell'artropatia in soggetti affetti da emofilia. 89
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 88
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 88
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. 88
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 88
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 88
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 84
Mitral valve prolapse and prothrombotic risk factors in children and adolescents with migraine with aura and other idiopathic headaches 84
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 84
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 84
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 82
Castleman's disease with coagulation defect. A case report. 82
In vitro and in vivo effects of desmopressin on platelet function 82
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 81
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 81
Liver damage and homocysteine plasma levels in haemophilia 80
Performance in sports of children and adolescents with hereditary bleeding disorders 80
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 79
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 79
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 78
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 78
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 77
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 77
Desmopressin and platelets: In vitro and in vivo studies 76
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 76
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 75
Clotting alterations in primary systemic amyloidosis 75
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 74
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 73
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 73
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 72
Platelet function after in vivo and in vitro treatment with thrombolytic agents 72
Homocysteine, vitamin b12 and folic acid levels in psoriasi patients and correlation with disease severity. 72
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 71
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 70
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 69
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 68
Bleeding tendency of unknown origin and protein Z levels. 68
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 67
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. 67
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 67
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 65
Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage. 64
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study 64
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 64
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 63
Expression of dipeptidylaminopeptidase IV-CD26 in circulating lymphocytes of homophilic subjects 63
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 63
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 62
Homocysteine and liver steatosis in HCV infected haemophiliacs 62
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 60
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 60
Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by agnogenic myeloid metaplasia 60
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 57
HEPARIN INFUSION FACILITATES PLATELETS ACTIVABILITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO HAVE UNDERGONE THROMBOLYTIC THERAPY 56
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 53
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 53
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 52
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 51
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 48
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 46
Interobserver reliability of ultrasound assessment of haemophilic arthropathy: Radiologist vs. non-radiologist 43
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. 38
Preoperative bleeding risk assessment with ISTH-BAT and laboratory tests in patients undergoing elective surgery: A prospective cohort study 36
Totale 7.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.017
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021376 0 0 0 0 0 77 5 94 15 90 77 18
2021/2022418 12 0 13 9 3 10 13 20 33 13 50 242
2022/20231.270 146 85 2 111 148 137 0 62 508 17 35 19
2023/2024363 67 51 18 31 48 81 0 34 5 10 14 4
2024/20251.070 15 97 25 33 21 47 21 78 269 29 139 296
2025/20261.479 233 202 295 347 322 80 0 0 0 0 0 0
Totale 7.186